The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin Sensitization
Open accessAbstract
OBJECTIVE: This study sought to identify the profile of circulating microRNAs (miRNAs) in type 2 diabetes (T2D) and its response to changes in insulin sensitivity. RESEARCH DESIGN AND METHODS: The circulating miRNA profile was assessed in a pilot study of 12 men: 6 with normal glucose tolerance (NGT) and 6 T2D patients. The association of 10 circulating miRNAs with T2D was cross-sectionally validated in an extended sample of 45 NGT vs. 48 T2D subjects (65 nonobese and 28 obese men) and longitudinally in 35 T2D patients who were recruited in a randomized, double-blinded, and placebo-controlled 3-month trial of metformin treatment. Circulating miRNAs were also measured in seven healthy volunteers before and after a 6-h hyperinsulinemic-euglycemic clamp and insulin plus intralipid/heparin infusion. RESULTS: Cross-sectional studies disclosed a marked increase of miR-140-5p, miR-142-3p, and miR-222 and decreased miR-423-5p, miR-125b, miR-192, miR-195, miR-130b, miR-532-5p, and miR-126 in T2D patients. Multiple linear regression analyses revealed that miR-140-5p and miR-423-5p contributed independently to explain 49.5% (P < 0.0001) of fasting glucose variance after controlling for confounders. A discriminant function of four miRNAs (miR-140-5p, miR-423-5p, miR-195, and miR-126) was specific for T2D with an accuracy of 89.2% (P < 0.0001). Metformin (but not placebo) led to significant changes in circulating miR-192 (49.5%; P = 0.022), miR-140-5p (−15.8%; P = 0.004), and miR-222 (−47.2%; P = 0.03), in parallel to decreased fasting glucose and HbA1c. Furthermore, while insulin infusion during clamp decreased miR-222 (−62%; P = 0.002), the intralipid/heparin mixture increased circulating miR-222 (163%; P = 0.015) and miR-140-5p (67.5%; P = 0.05). CONCLUSIONS: This study depicts the close association between variations in circulating miRNAs and T2D and their potential relevance in insulin sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741
Characterization of extracellular circulating microRNA
Turchinovich, A., Weiz, L., Langheinz, A., & Burwinkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr254 · Cited by 1,941
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.226357 · Cited by 1,283
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
The use of relative operating characteristic (ROC) curves in test performance evaluation.
Beck, & Shultz, E. K. (1986) · PubMed · Cited by 621
Poste, G. (2011) · Nature · doi:10.1038/469156a · Cited by 582
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets
van Rooij, E., & Olson, E. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33099 · Cited by 553
Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., & Zhang, C. (2009) · Circulation Research · doi:10.1161/circresaha.108.185363 · Cited by 553
Kong, L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., et al. (2011) · Acta Diabetologica · doi:10.1007/s00592-010-0226-0 · Cited by 529
Targeting the Circulating MicroRNA Signature of Obesity
Ortega, F. J., Mercader, J. M., Catalán, V., Moreno-Navarrete, J. M., Pueyo, N., Sabater, M., Gómez-Ambrosi, J., Anglada, R., Fernández-Formoso, J. A., Ricart, W., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.195776 · Cited by 443
Self-citationBaggish, A. L., Hale, A., Weiner, R. B., Lewis, G. D., Systrom, D., Wang, F., Wang, T. J., & Chan, S. Y. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.213363 · Cited by 431
Circulating miRNA Profiles in Patients with Metabolic Syndrome
Karolina, D. S., Tavintharan, S., Armugam, A., Sepramaniam, S., Pek, S. L. T., Wong, M. T. K., Lim, S. C., Sum, C. F., & Jeyaseelan, K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1996 · Cited by 409
MiRNA Expression Profile of Human Subcutaneous Adipose and during Adipocyte Differentiation
Ortega, F. J., Moreno-Navarrete, J. M., Pardo, G., Sabater, M., Hummel, M., Ferrer, A., Rodriguez-Hermosa, J. I., Ruiz, B., Ricart, W., Peral, B., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009022 · Cited by 405
Self-citationLoss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy
Krupa, A., Jenkins, R., Luo, D. D., Lewis, A., Phillips, A., & Fraser, D. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050530 · Cited by 348
Diabetes mellitus, a microRNA-related disease?
Guay, C., Roggli, E., Nesca, V., Jacovetti, C., & Regazzi, R. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.009 · Cited by 300
Herrera, B. M., Lockstone, H. E., Taylor, J. M., Ria, M., Barrett, A., Collins, S., Kaisaki, P., Argoud, K., Fernandez, C., Travers, M. E., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1667-2 · Cited by 289
Profiling of circulating microRNAs: from single biomarkers to re-wired networks
Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S., & Mayr, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr266 · Cited by 258
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome
Joyce, C. E., Zhou, X., Xia, J., Ryan, C., Thrash, B., Menter, A., Zhang, W., & Bowcock, A. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr331 · Cited by 246
Extracellular/circulating microRNAs and their potential role in cardiovascular disease.
Zhu, H., & Fan, G. (2011) · Europe PMC (PubMed Central) · Cited by 191
Meta-regulation: microRNA regulation of glucose and lipid metabolism
Lynn, F. C. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.05.007 · Cited by 187
Circulating MicroRNAs and Aerobic Fitness – The HUNT-Study
Bye, A., Røsjø, H., Aspenes, S. T., Condorelli, G., Omland, T., & Wisløff, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057496 · Cited by 165
MicroRNA Expression in Alpha and Beta Cells of Human Pancreatic Islets
Klein, D., Misawa, R., Bravo-Egaña, V., Vargas, N., Rosero, S., Piroso, J., Ichii, H., Umland, O., Zhijie, J., Tsinoremas, N. F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055064 · Cited by 135
Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140.
Nicolás, F. E., Pais, H., Schwach, F., Lindow, M., Kauppinen, S., Moulton, V., & Dalmay, T. (2008) · RNA: A publication of the RNA Society · doi:10.1261/rna.1221108 · Cited by 128
Innate immunity, insulin resistance and type 2 diabetes
Fernández‐Real, J. M., & Pickup, J. C. (2011) · Diabetologia · doi:10.1007/s00125-011-2387-y · Cited by 121
Self-citationComplement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance
Moreno‐Navarrete, J. M., Martínez‐Barricarte, R., Catalán, V., Sabater, M., Gómez‐Ambrosi, J., Ortega, F. J., Ricart, W., Blüher, M., Frühbeck, G., de Córdoba, S. R., et al. (2009) · Diabetes · doi:10.2337/db09-0700 · Cited by 120
Self-citationCirculating miR-142-3p levels in patients with systemic sclerosis
Makino, K., Jinnin, M., Kajihara, I., Honda, N., Sakai, K., Masuguchi, S., Fukushima, S., Inoue, Y., & Ihn, H. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2011.04158.x · Cited by 101
MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery
Mayr, M., Zampetaki, A., Willeit, P., Willeit, J., & Kiechl, S. J. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300141 · Cited by 99
Karczewska‐Kupczewska, M., Kowalska, I., Nikołajuk, A., Adamska, A., Zielińska, M., Kamińska, N., Otziomek, E., Górska, M., & Strączkowski, M. (2011) · Diabetes Care · doi:10.2337/dc11-1295 · Cited by 79
Self-citationColeman, C. B., Lightell, D., Moss, S. C., Bates, M. J., Parrino, P. E., & Woods, T. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.019 · Cited by 74
Are extracellular microRNAs involved in type 2 diabetes and related pathologies?
Rome, S. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.02.018 · Cited by 48
Self-citationFasting Plasma Glucose in the Screening for Type 2 Diabetes in Morbidly Obese Subjects
Hofsø, D., Jenssen, T. G., Hager, H. B., Røislien, J., & Hjelmesaeth, J. S. (2009) · Obesity Surgery · doi:10.1007/s11695-009-0022-5 · Cited by 44
The influence of insulin infusion on the metabolism of amyloid β peptides in plasma
Karczewska‐Kupczewska, M., Lelental, N., Adamska, A., Nikołajuk, A., Kowalska, I., Górska, M., Zimmermann, R., Kornhuber, J., Strączkowski, M., & Lewczuk, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.013 · Cited by 18
Self-citation
Cited by
Ying, W., Riopel, M., Bandyopadhyay, G., Dong, Y., Birmingham, A., Seo, J. B., Ofrecio, J. M., Wollam, J., Hernandez-Carretero, A., Fu, W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.035 · Cited by 1,191
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
Kahn, C. R., Wang, G., & Lee, K. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129187 · Cited by 661
Cardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D. J., & Mather, K. J. (2017) · Translational Research · doi:10.1016/j.trsl.2017.01.001 · Cited by 568
MicroRNA regulatory networks in human adipose tissue and obesity
Arner, P., & Kulyté, A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.25 · Cited by 457
Metadata
- Authors
- Ortega, F. J., Mercader, J. M., Moreno-Navarrete, J. M., Rovira, O., Guerra, E., Esteve, E., Xifra, G., Martínez, C., Ricart, W., Rieusset, J., Rome, S., Karczewska-Kupczewska, M., Straczkowski, M., & Fernández-Real, J. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-04-10
- Volume
- 37
- Issue
- 5
- Pages
- 1375-1383
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2132892030
- Cited by
- 362
- References
- 37
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.